Literature DB >> 9120050

Fate of developing astrocytes in the optic nerve of the myelin-deficient rat.

G Struckhoff1, C Przyrembel, M Bähr, A Gocht.   

Abstract

There is considerable debate on the development of a glial cell line in the rat optic nerve, which is characterized by the specific expression of the A2B5 and HNK-1 epitopes. This cell line has been assumed to give rise to oligodendrocytes and so-called type 2 astrocytes. However, it is doubtful that the latter cell type really exists in vivo. In the present study, we have addressed this question by investigating the development of astrocytes in the myelin-deficient (md) rat, which is characterized by dysmyelination and loss of oligodendrocytes. Defective oligodendrocytes were observed by the third postnatal day, well before the generation of type 2 astrocytes. Consequently, the number of type 2 astrocytes was reduced in cultures prepared from optic nerves of md rats vs. controls. This finding was not paralleled in vivo; i.e., no dying astrocytes were observed in md sections by conventional electron microscopy. However, immunoreactivity against the HNK-1 epitope was enhanced in md compared to control sections. Ultrastructurally, HNK-1 immunoreactivity was detected predominantly on the axonal surface at astroaxonal contact sites, which were found only at the nodes of Ranvier within controls but extended to the whole axonal surface in md animals. Only a minor portion of the immunoreactivity derived from glial cells, presumably from oligodendrocytes at the paranodal region in controls. Thus, the HNK-1 epitope is not a useful antigen for distinguishing astrocytes in the rat optic nerve. Accordingly, our results do not provide evidence for the existence of specialized type 2 astrocytes in vivo. In vitro, these cells are probably only oligodendrocytes that mimic some astroglial features if grown in serum-containing media.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9120050     DOI: 10.1002/(sici)1096-9861(19970203)378:1<105::aid-cne6>3.0.co;2-8

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  2 in total

1.  Endpoints in myelin-deficient (MD) rats.

Authors:  Jacek M Kwiecien; Kathleen H Delaney
Journal:  Comp Med       Date:  2010-10       Impact factor: 0.982

2.  Genetic dysmyelination alters the molecular architecture of the nodal region.

Authors:  Edgardo J Arroyo; Theodore Xu; Judith Grinspan; Stephen Lambert; S Rock Levinson; Peter J Brophy; Elior Peles; Steven S Scherer
Journal:  J Neurosci       Date:  2002-03-01       Impact factor: 6.167

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.